未登录

M

Maria Dumitrascuta

University of Innsbruck

H指数:9

被引数:223

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bifunctional Peptidomimetic G Protein-Biased Mu-Opioid Receptor Agonist and Neuropeptide FF Receptor Antagonist KGFF09 Shows Efficacy in Visceral Pain without Rewarding Effects after Subcutaneous Administration in Mice

IF4.6

2022-12-115

OAAI

Antinociceptive Efficacy of the μ-Opioid/Nociceptin Peptide-Based Hybrid KGNOP1 in Inflammatory Pain without Rewarding Effects in Mice: An Experimental Assessment and Molecular Docking

IF4.6

2021-05-2812

OAAI

Optimized Opioid-Neurotensin Multitarget Peptides: From Design to Structure-Activity Relationship Studies

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2020-09-0923

OAAI

Mechanistic Understanding of Peptide Analogues, DALDA, [Dmt1]DALDA, and KGOP01, Binding to the Mu Opioid Receptor

肽类似物DALDA，[Dmt1]DALDA和KGOP01与Mu阿片受体结合的机制理解

IF4.6

2020-04-2917

OAAI

N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective μ Opioid Receptor Ligands into Dual μ/δ Opioid Receptor Agonists

SCIENTIFIC REPORTS

IF3.9

2020-03-2715

OAAI

Fatty acid suppression of glial activation prevents central neuropathic pain after spinal cord injury

IF5.5

2019-07-2921

OAAI

Biodegradable Amphipathic Peptide Hydrogels as Extended-Release System for Opioid Peptides

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2018-10-1627

OAAI

A bifunctional-biased mu-opioid agonist-neuropeptide FF receptor antagonist as analgesic with improved acute and chronic side effects

IF5.5

2018-04-2629

OAAI

Synthesis, Pharmacology, and Molecular Docking Studies on 6-Desoxo-N-methylmorphinans as Potent μ-Opioid Receptor Agonists

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2017-11-0317

OAAI